What Are Peptides? The Complete Science Guide

Key Takeaways

• Peptides are short chains of amino acids (2–50 amino acids long) that act as signaling molecules throughout your body
• Your body produces hundreds of endogenous peptides that function as hormones, neurotransmitters, and growth factors
• Therapeutic peptides used in medicine mimic or enhance these natural signaling pathways
• Over 80 peptide-based drugs have received FDA approval, with hundreds more in clinical trials

Table of Contents

• Peptides: The Basic Definition
• How Peptides Differ from Proteins
• How Your Body Makes Peptides
• Types of Peptides by Function
• How Peptides Work at the Cellular Level
• Therapeutic Peptides in Medicine
• Common Peptides Used in Therapy
• Are Peptides Safe?
• FAQ
• Sources

Peptides: The Basic Definition

Peptides are short chains of amino acids linked together by peptide bonds. If you remember anything from biology class, proteins are made of amino acids. Peptides are the same building blocks, just shorter.

The standard definition: a chain of 2–50 amino acids is a peptide. Anything longer is generally classified as a protein [1]. Your body uses 20 different amino acids to build peptides, and the specific sequence determines what that peptide does. Change one amino acid in the chain, and you can completely alter the molecule’s function.

This matters for peptide therapy because therapeutic peptides are designed to match or closely mimic the structure of peptides your body already produces. They’re not foreign chemicals — they’re copies of molecules you’re already familiar with at a cellular level.

The term “peptide” comes from the Greek word “peptos,” meaning digested. Early biochemists discovered these molecules while studying protein digestion in the late 1800s. Since then, research has identified hundreds of biologically active peptides that control everything from appetite to wound healing to sleep [2]. For a broader overview of therapeutic applications, see our guide on how peptides work.

How Peptides Differ from Proteins

The line between peptides and proteins isn’t perfectly sharp, but the functional differences matter:

Size. Peptides contain 2–50 amino acids. Proteins contain 50+ amino acids, often hundreds or thousands. Insulin, at 51 amino acids, sits right at the boundary and is sometimes classified as either [3].

Structure. Proteins fold into complex three-dimensional shapes (secondary, tertiary, and quaternary structures). Peptides are generally too short to form these elaborate structures, though some do adopt specific conformations.

Stability. Peptides break down faster than proteins in the body. This is why many therapeutic peptides need to be injected rather than taken orally — stomach acid and digestive enzymes destroy most peptides before they can reach the bloodstream [4].

Function. Both peptides and proteins do biological work, but peptides tend to act as signaling molecules — they carry messages between cells. Proteins more often serve structural roles (collagen, keratin) or catalytic roles (enzymes).

Understanding this distinction helps explain why different peptide types have different delivery methods and half-lives in the body.

How Your Body Makes Peptides

Your cells produce peptides through a process called translation, the same way they make proteins. Here’s the short version:

DNA contains the genetic instructions. Those instructions get transcribed into messenger RNA (mRNA). Ribosomes in the cell read the mRNA and assemble amino acids into a peptide chain [5].

But most biologically active peptides aren’t built directly. Instead, your cells produce larger precursor molecules called prepropeptides. These get processed in several steps:

1. The signal sequence (a short tag that directs the peptide to the right cellular compartment) gets clipped off, creating a propeptide
2. Specific enzymes called endopeptidases cut the propeptide at precise locations
3. The resulting fragments are the active peptides that get packaged and secreted [6]

One precursor protein can yield multiple active peptides. Proopiomelanocortin (POMC), for example, is a single precursor that gets cut into ACTH (which stimulates cortisol production), beta-endorphin (a natural painkiller), and melanocyte-stimulating hormone (which affects skin pigmentation) [7].

This is a remarkably efficient system. Your body gets several functional molecules from one manufacturing run.

Types of Peptides by Function

Peptides serve different roles depending on where they act and what receptors they target. The major categories:

Peptide Hormones

These travel through the bloodstream to reach distant target cells. Examples your body makes every day:

• Insulin (51 amino acids) — regulates blood sugar by telling cells to absorb glucose [3]
• Glucagon (29 amino acids) — raises blood sugar by signaling the liver to release stored glucose
• Oxytocin (9 amino acids) — involved in bonding, labor contractions, and milk ejection
• ADH/Vasopressin (9 amino acids) — controls water retention in the kidneys

Peptide hormones work by binding to receptors on the outside of target cells (they’re too large and too water-soluble to cross cell membranes directly). This triggers intracellular signaling cascades that change cell behavior [8].

Neuropeptides

These function in the nervous system, often acting as neurotransmitters or neuromodulators:

• Endorphins — your body’s natural painkillers, structurally similar to opioids
• Substance P — transmits pain signals
• Neuropeptide Y — regulates appetite and energy balance
• Orexin/Hypocretin — controls wakefulness and arousal [9]

Many neuropeptides double as hormones in other contexts. The distinction depends on where they’re released and what they’re acting on.

Antimicrobial Peptides

Your immune system produces peptides that directly kill bacteria, fungi, and viruses:

• Defensins — found in skin, lungs, and intestinal lining
• Cathelicidins — produced by white blood cells
• Histatins — present in saliva [10]

These peptides punch holes in microbial cell membranes or disrupt their internal processes. They’re part of the innate immune system — the first line of defense that works without needing to “learn” about specific pathogens.

Growth Factors and Signaling Peptides

These coordinate tissue growth, repair, and maintenance:

• Growth hormone-releasing hormone (GHRH) — tells the pituitary gland to release growth hormone
• GHK-Cu — a tripeptide (just three amino acids) involved in wound healing and collagen production. Learn more in our GHK-Cu guide.
• BPC-157 — a 15-amino-acid peptide derived from gastric juice, studied for tissue repair. Our BPC-157 guide covers the research in detail.

For a complete reference of peptides used in therapeutic settings, see our list of peptides.

How Peptides Work at the Cellular Level

When a peptide reaches its target cell, it binds to a specific receptor — usually a G-protein coupled receptor (GPCR) or a receptor tyrosine kinase on the cell surface [8].

Think of it like a key fitting a lock. The peptide (key) binds to the receptor (lock), and this triggers a cascade of events inside the cell:

1. The receptor changes shape
2. This activates intracellular signaling proteins (like G-proteins or kinases)
3. These proteins amplify the signal, activating dozens of downstream molecules
4. The cell changes its behavior — producing new proteins, dividing, releasing stored molecules, or adjusting its metabolism

This amplification effect is why tiny amounts of peptides can produce large biological responses. A few nanograms of a peptide hormone can alter the function of millions of cells [11].

Peptide signaling is also self-limiting. Enzymes called peptidases break down peptides in the bloodstream and tissues, giving most peptides a half-life of minutes to hours. This is different from steroid hormones, which can persist for days. The short half-life means peptide effects are more precise and controllable, but it also means therapeutic peptides often need frequent dosing [4].

Therapeutic Peptides in Medicine

The pharmaceutical industry has been developing peptide drugs for decades. As of 2024, over 80 peptide therapeutics have received FDA approval, with more than 170 in active clinical trials and roughly 600 in preclinical development [12].

Some of the most commercially successful drugs in history are peptides:

• Insulin (approved 1982) — the first commercially available peptide drug, now used by over 8 million Americans
• Liraglutide/Semaglutide (Ozempic, Wegovy) — GLP-1 receptor agonists for diabetes and weight loss that generated over $20 billion in revenue in 2023 [13]
• Leuprolide (Lupron) — used for prostate cancer, endometriosis, and precocious puberty
• Octreotide (Sandostatin) — treats acromegaly and certain tumors

Beyond FDA-approved drugs, compounding pharmacies produce peptides prescribed by physicians for off-label therapeutic use. This is where most of the peptides discussed in peptide therapy fall — compounds like BPC-157, CJC-1295/Ipamorelin, and GHK-Cu that have research supporting their use but haven’t gone through the full FDA approval process.

The distinction matters: FDA-approved peptide drugs have completed rigorous clinical trials. Compounded peptides rely on smaller studies, often preclinical, plus clinical observation by prescribing physicians.

Common Peptides Used in Therapy

Here’s a snapshot of the peptides most commonly prescribed in clinical settings:

For Recovery and Healing

BPC-157 — A 15-amino-acid fragment of a protein found in gastric juice. Animal studies show accelerated healing of tendons, ligaments, muscle, and gut tissue [14]. It’s one of the most widely prescribed therapeutic peptides. Our BPC-157 guide covers dosing and research.

TB-500 — A synthetic version of thymosin beta-4, involved in cell migration and blood vessel formation. Studied for muscle and tissue repair [15].

For Weight Loss

Semaglutide — A GLP-1 receptor agonist that reduces appetite and slows gastric emptying. Clinical trials showed 15–17% body weight reduction over 68 weeks [13]. See our guide on peptides for weight loss for a detailed comparison of options.

For Anti-Aging and Skin

GHK-Cu — A copper-binding tripeptide that stimulates collagen synthesis, reduces inflammation, and promotes wound healing. Found naturally in blood plasma, with concentrations declining significantly after age 60 [16]. More details in our GHK-Cu guide.

For Growth Hormone Support

CJC-1295/Ipamorelin — A combination that stimulates growth hormone release from the pituitary gland. Used for body composition, sleep quality, and recovery [17].

Sermorelin — A 29-amino-acid peptide that mimics GHRH. It was FDA-approved for pediatric growth hormone deficiency and is now commonly used off-label in adults.

Are Peptides Safe?

The safety profile of peptides depends entirely on which peptide, what dose, and who’s taking it.

FDA-approved peptide drugs have well-documented safety profiles established through clinical trials. Compounded therapeutic peptides have less formal safety data but generally carry a favorable risk profile when prescribed and monitored by a physician [18].

Common peptide side effects include:

• Injection site reactions (redness, swelling, itching)
• Nausea, particularly with GLP-1 peptides
• Headache during initial dosing
• Water retention with growth hormone secretagogues
• Fatigue during dose adjustment periods

Serious adverse events are uncommon with properly dosed therapeutic peptides, but they’re not zero-risk. Growth hormone secretagogues can affect blood sugar regulation. GLP-1 agonists carry warnings about pancreatitis and gallbladder disease. BPC-157’s long-term safety in humans hasn’t been formally studied [14].

The biggest safety concern isn’t the peptides themselves — it’s sourcing. Peptides purchased from unregulated vendors (labeled “for research use only”) may contain impurities, incorrect concentrations, or different compounds entirely. A 2019 analysis of online peptide vendors found significant discrepancies between labeled and actual content in many products [19].

Working with a physician who prescribes through a licensed compounding pharmacy eliminates the sourcing risk. That’s the core argument for medical supervision in peptide therapy.

FAQ

What exactly is a peptide?▼

A peptide is a short chain of amino acids (2–50 amino acids long) linked by peptide bonds. Your body produces hundreds of peptides naturally — they act as hormones, neurotransmitters, growth factors, and immune defense molecules. Therapeutic peptides used in medicine mimic these natural compounds.

Are peptides the same as proteins?▼

No. Peptides and proteins are both made of amino acids, but peptides are shorter (2–50 amino acids) while proteins are longer (50+ amino acids). Proteins fold into complex 3D structures; peptides generally don’t. Peptides tend to act as signaling molecules, while proteins more often serve structural or enzymatic roles.

Are peptides steroids?▼

No. Peptides and steroids are completely different classes of molecules. Peptides are made of amino acids and work by binding to receptors on cell surfaces. Steroids are lipid-based molecules that can cross cell membranes and bind to intracellular receptors. They have different mechanisms, different effects, and different side effect profiles.

How many peptides does the human body make?▼

The human body produces over 7,000 known peptides [12]. These include hormones (insulin, oxytocin), neurotransmitters (endorphins, substance P), antimicrobial peptides (defensins), and signaling molecules (growth factors). New peptides are still being discovered and characterized.

Do peptides actually work for therapy?▼

The evidence varies by peptide. Some — like insulin, semaglutide, and leuprolide — have extensive clinical trial data proving efficacy. Others used in compounded form, like BPC-157 and CJC-1295/Ipamorelin, have strong preclinical evidence and clinical observation but lack large-scale human trials. The distinction between “FDA-approved” and “clinically used but not FDA-approved” is worth understanding before starting any protocol.

Sources

1. Fosgerau K, Hoffmann T. Peptide therapeutics: current status and future directions. Drug Discovery Today. 2015;20(1):122–128. https://doi.org/10.1016/j.drudis.2014.10.003

2. Kastin AJ, ed. Handbook of Biologically Active Peptides. 2nd ed. Academic Press; 2013.

3. Wilcox G. Insulin and insulin resistance. Clinical Biochemist Reviews. 2005;26(2):19–39. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1204764/

4. Di L. Strategic approaches to optimizing peptide ADME properties. AAPS Journal. 2015;17(1):134–143. https://doi.org/10.1208/s12248-014-9687-3

5. Alberts B, et al. Molecular Biology of the Cell. 6th ed. Garland Science; 2014. Chapter 6: From DNA to RNA to Protein.

6. Hook V, et al. Proteases for processing proneuropeptides into peptide neurotransmitters and hormones. Annual Review of Pharmacology and Toxicology. 2008;48:393–423. https://doi.org/10.1146/annurev.pharmtox.48.113006.094812

7. Cawley NX, et al. The biology of prohormone convertases. Endocrine Reviews. 2012;33(5):836–857.

8. Lagerström MC, Schiöth HB. Structural diversity of G protein-coupled receptors and significance for drug discovery. Nature Reviews Drug Discovery. 2008;7:339–357. https://doi.org/10.1038/nrd2518

9. Purves D, et al. Neuroscience. 6th ed. Sinauer Associates; 2018. Chapter 6: Neurotransmitters. https://www.ncbi.nlm.nih.gov/books/NBK10873/

10. Hancock RE, Sahl HG. Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nature Biotechnology. 2006;24(12):1551–1557. https://doi.org/10.1038/nbt1267

11. Rang HP, et al. Rang and Dale’s Pharmacology. 9th ed. Elsevier; 2019. Chapter 33: The pituitary and the adrenal cortex.

12. Muttenthaler M, et al. Trends in peptide drug discovery. Nature Reviews Drug Discovery. 2021;20:309–325. https://doi.org/10.1038/s41573-020-00135-8

13. Wilding JPH, et al. Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine. 2021;384(11):989–1002. https://doi.org/10.1056/NEJMoa2032183

14. Gwyer D, Wragg NM, Wilson SL. Gastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healing. Cell and Tissue Research. 2019;377(2):153–159. https://doi.org/10.1007/s00441-019-03016-8

15. Kleinman HK, Sosne G. Thymosin β4 and the eye: the foundation for clinical studies. Annals of the New York Academy of Sciences. 2012;1269(1):1–6. https://doi.org/10.1111/j.1749-6632.2012.06744.x

16. Pickart L, Vasquez-Soltero JM, Margolina A. GHK peptide as a natural modulator of multiple cellular pathways in skin regeneration. BioMed Research International. 2015;2015:648108. https://doi.org/10.1155/2015/648108

17. Sigalos JT, Pastuszak AW. The safety and efficacy of growth hormone secretagogues. Sexual Medicine Reviews. 2018;6(1):45–53. https://doi.org/10.1016/j.sxmr.2017.02.004

18. Henninot A, Collins JC, Nuss JM. The current state of peptide drug discovery: back to the future? Journal of Medicinal Chemistry. 2018;61(4):1382–1414. https://doi.org/10.1021/acs.jmedchem.7b00318

19. Van Dorsten RT, et al. Quality assessment of unregulated dietary supplements and peptides sold online. Journal of Clinical and Translational Science. 2019;3(S1):137. https://doi.org/10.1017/cts.2019.305